Drug Detail

Information about Avapritinib or Regorafenib

Generic Name	Avapritinib or Regorafenib
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	KIT and PDGFRA protein based
Strategy	Block KIT/PDGFRA
Drug Category	KIT/PDGFRA inhibitor + D842V inhibitor

This drug pair is in a phase 3 comparison trial for 3rd line treatment of resistant GIST. See the individual drug entries for avapritinib or regorafenib for details about each drug.